Hyperostosis-Hyperphosphatemia Syndrome: A Congenital Disorder of O-Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23-Reference-Cited by-同舟云学术

Hyperostosis-Hyperphosphatemia Syndrome: A Congenital Disorder of O-Glycosylation Associated With Augmented Processing of Fibroblast Growth Factor 23

Published:2006-11-13 Issue:2 Volume:22 Page:235-242
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Frishberg Yaacov,Ito Nobuaki,Rinat Choni,Yamazaki Yuji,Feinstein Sofia,Urakawa Itaru,Navon-Elkan Paulina,Becker-Cohen Rachel,Yamashita Takeyoshi,Araya Kaori,Igarashi Takashi,Fujita Toshiro,Fukumoto Seiji

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Cortical hyperostosis with hyperphosphatemia: A new syndrome?;Melhem;J Pediatr,1970

2. The syndrome of hyperostosis and hyperphosphatemia;Mikati;J Pediatr,1981

3. Hyperphosphatemia associated with cortical hyperostosis and tumoral calcinosis;Wilson;J Pediatr,1989

4. Congenital disorders of glycosylation (CDG): It's all in it!;Jaeken;J Inherit Metab Dis,2003

5. Congenital disorders of glycosylation: Review of their molecular bases, clinical presentations and specific therapies;Marquardt;Eur J Pediatr,2003

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Pathogenic Variant in <i>Fibroblast Growth Factor 23</i> outside the Furin-Recognizing RXXR Motif in an Autosomal Dominant Hypophosphatemic Rickets Patient;Hormone Research in Paediatrics;2024-03-15

2. Runx2 Regulates Galnt3 and Fgf23 Expressions and Galnt3 Decelerates Osteoid Mineralization by Stabilizing Fgf23;International Journal of Molecular Sciences;2024-02-14

3. Regulation of FGF23 Production in Osteocytes;Current Osteoporosis Reports;2024-02-09

4. Phosphate-sensing mechanisms and functions of phosphate as a first messenger;Endocrine Journal;2024

5. Phosphate metabolism, hyperphosphatemia, and hypophosphatemia;Reference Module in Biomedical Sciences;2024